Pathstone Holdings
RGEN icon

Pathstone Holdings’s Repligen RGEN Stock Holding History

Pathstone Holdings’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.48M Sell
21,046
-3,228
-13% -$451K 0.01% 911
2025
Q4 		$3.98M Sell
24,274
-1,815
-7% -$284K 0.02% 661
2025
Q3 		$3.49M Buy
26,089
+3,521
+16% +$428K 0.01% 718
2025
Q2 		$2.81M Sell
22,568
-11,938
-35% -$1.52M 0.01% 807
2025
Q1 		$4.39M Buy
34,506
+14,247
+70% +$2.19M 0.02% 607
2024
Q4 		$2.92M Sell
20,259
-2,025
-9% -$290K 0.01% 777
2024
Q3 		$3.32M Buy
22,284
+5,459
+32% +$783K 0.01% 716
2024
Q2 		$2.12M Sell
16,825
-607
-3% -$95.1K 0.01% 898
2024
Q1 		$3.21M Buy
17,432
+6,183
+55% +$1.18M 0.01% 689
2023
Q4 		$2.02M Buy
+11,249
New +$1.75M 0.01% 735

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Pathstone Holdings's RGEN Position: Q1 2026 in Review

Pathstone Holdings reduced its Repligen (RGEN) stake by 13% in Q1 2026, selling an estimated $451K and leaving 21,046 shares worth $2.48M. The position accounts for 0.01% of the portfolio, ranked #911.

Pathstone Holdings first reported a position in RGEN in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.39M in Q1 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Pathstone Holdings held 21,046 shares of Repligen worth $2.48M as of Q1 2026.
  • Pathstone Holdings sold 3,228 Repligen shares in Q1 2026, an estimated $451K.
  • Repligen made up 0.01% of Pathstone Holdings's portfolio in Q1 2026, its #911 holding.
  • Pathstone Holdings first reported a position in Repligen in Q4 2023 and has held it in 10 quarters since.
  • Pathstone Holdings's Repligen position peaked at $4.39M in Q1 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.